Multiple Myeloma (Kahler’s Disease):グローバル臨床試験レビューH2, 2013...市場調査レポートについてご紹介

【英文タイトル】Multiple Myeloma (Kahler's Disease) Global Clinical Trials Review, H2, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Multiple Myeloma (Kahler’s Disease) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Multiple Myeloma (Kahler’s Disease) 23
Subjects Recruited Over a Period of Time 41
Prominent Sponsors 42
Top Companies Participating in Multiple Myeloma (Kahler’s Disease) Therapeutics Clinical Trials 44
Prominent Drug Comparison 46
Clinical Trial Profiles 47
Clinical Trial Overview of Top Companies 47
Celgene Corporation 47
Clinical Trial Overview of Celgene Corporation 47
Johnson & Johnson 58
Clinical Trial Overview of Johnson & Johnson 58
Takeda Pharmaceutical Company Limited 65
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 65
Novartis AG 72
Clinical Trial Overview of Novartis AG 72
Mayo Clinic 77
Clinical Trial Overview of Mayo Clinic 77
Onyx Pharmaceuticals, Inc. 81
Clinical Trial Overview of Onyx Pharmaceuticals, Inc. 81
F. Hoffmann-La Roche Ltd. 85
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 85
Sanofi 88
Clinical Trial Overview of Sanofi 88
Merck & Co., Inc. 91
Clinical Trial Overview of Merck & Co., Inc. 91
Clinical Trial Overview of Top Institutes / Government 93
National Cancer Institute 93
Clinical Trial Overview of National Cancer Institute 93
The University of Texas M. D. Anderson Cancer Center 105
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 105
Fred Hutchinson Cancer Research Center 109
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 109
University of Arkansas 115
Clinical Trial Overview of University of Arkansas 115
Memorial Sloan Kettering Cancer Center 118
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 118
Sidney Kimmel Comprehensive Cancer Center 122
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center 122
H. Lee Moffitt Cancer Center & Research Institute 125
Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute 125
Barbara Ann Karmanos Cancer Institute 127
Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute 127
Dana-Farber Cancer Institute, Inc. 129
Clinical Trial Overview of Dana-Farber Cancer Institute, Inc. 129
Case Comprehensive Cancer Center 131
Clinical Trial Overview of Case Comprehensive Cancer Center 131
Five Key Clinical Profiles 133
Appendix 306
Abbreviations 306
Definitions 306
Research Methodology 307
Secondary Research 307
About GlobalData 308
Contact Us 308
Disclaimer 308
Source 309


【レポート販売概要】

■ タイトル:Multiple Myeloma (Kahler’s Disease):グローバル臨床試験レビューH2, 2013
■ 英文:Multiple Myeloma (Kahler's Disease) Global Clinical Trials Review, H2, 2013
■ 発行日:2013年11月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403162939
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。